市场调查报告书
商品编码
1532135
全球血管通路装置市场评估:依产品类型、应用、最终用户、地区、机会、预测(2017-2031)Vascular Access Devices Market Assessment, By Product Type, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
全球血管通路装置市场规模预计将从2023年的 36.3亿美元增至2031年的 57.1亿美元,预计2024-2031年年复合成长率为 5.83%。由于疾病负担增加、住院人数增加和医疗保健系统改善,预计市场在预测期内将以相当大的速度扩张。
血管通路装置是用来将药物、液体、血液和营养物质注入血管的插入物。这些装置包括週边插入中心静脉导管(PICC)、中心静脉导管、植入式输液港和周边静脉导管(PIVC)。随着医疗服务和医疗器材的不断发展,血管通路器材在设计、材料和影像技术整合方面也不断发展。血管通路装置的进步提高了生物相容性、灵活性,并采用了新材料,改善了患者的治疗效果和生活品质。生活方式疾病负担的增加、技术进步以及微创手术的需求推动了对血管通路装置的需求不断成长。製造商一直致力于改进设备设计和材料,以改善患者治疗效果并减少併发症。
例如,2024年 5月,Teleflex Incorporated 推出了 Arrow EZ-IO 骨内通路手术托盘,增强了其骨内通路产品组合。它包括骨内通路所需的所有组件,并具有第一个经 FDA 批准的可在无菌环境中使用的电池供电驱动器。此托盘设计用于快速、精确地插入,解决临床医生在紧急情况下获得血管通路时所面临的挑战。然而,与长期使用导管相关的风险,例如感染和败血症,可能会对市场成长带来挑战。
慢性病负担的增加扩大了市场规模
全球慢性病负担不断加重,癌症、心血管疾病、泌尿系统疾病等慢性病盛行率不断上升,需要频繁、长期的化疗、透析和药物治疗。通路装置的需求,包括中心静脉导管和周边静脉导管。造成负担增加的另一个因素是越来越多的老年人更容易罹患此类疾病。由于目前的情况,预计未来对血管通路装置的需求将进一步增加。
例如,美国国立卫生研究院(NIH)估计,50 岁及以上患有至少一种慢性病的成年人数量将从2020年的 71,522,000 人增加到2050年的 142,660,000 人,预计增加 %。据估计,到2060年,将有 4,800 万人死于与健康相关的严重痛苦,占全球死亡人数的 47%,比2016年的 2,600 万人增加 87%。其中,83%预计发生在低收入和中等收入国家。根据世界卫生组织(WHO)估计,到2050年,地球上60岁以上的人口将增加一倍,达到21亿。
设计改善推动市场需求
血管通路装置包括中心静脉导管(CVC)、自体血管动静脉瘻管(AVF)和人工血管动静脉瘻管(AVG)。 CVC 尖端和护套设计的创新提高了通畅性和血流速度。 AVF 优于 CVC,因为它们不易凝血和感染,更可靠,并提供充足的血流。透过此类设计改进,AVF 成型设备具有引领市场成长的巨大动力。市场公司寻找机会推出具有增强设计的创新产品。例如,2023年 9月,Laminate Medical Technologies 宣布其 VasQ 外部血管支持(一种用于透析通路的 AVF 形成装置)已获得美国 FDA 批准。值得注意的是,在使用 VasQ 的临床试验中,80%的患者能够在开始治疗后一年内拔除中心静脉导管,与传统 AVF 相比,降低了感染风险。 VasQ 在 AVF 形成过程中从结构上增强血管,促进更好的动脉血流和功能。
本报告研究分析了全球血管通路器材市场,提供市场规模和预测、市场动态、主要参与者的现状和前景等。
Global vascular access devices market is projected to witness a CAGR of 5.83% during the forecast period 2024-2031, growing from USD 3.63 billion in 2023 to USD 5.71 billion in 2031. With increasing disease burden, rising hospitalization, and an improved healthcare system, the market of vascular access devices is anticipated to expand at a notable pace during the forecast period.
Vascular access devices are insertions used to administer drugs, fluids, blood, and nutrients in blood vessels. These devices include peripherally inserted central catheters (PICCs), central venous catheters, implantable ports, and peripheral intravenous catheters (PIVCs). With the never-ending evolution of healthcare services and medical devices, vascular access devices have evolved in terms of design, material, and integration of imaging technologies in it. Advancements in vascular access devices have improved biocompatibility, flexibility, and the adoption of novel materials, enhancing patient outcomes and quality of life. The rising demand for vascular access devices is driven by the growing burden of lifestyle diseases, technological advancements, and the need for minimally invasive procedures. Manufacturers are consistently working to enhance device design and materials to improve patient outcomes and reduce complications.
For instance, in May 2024, Teleflex Incorporated launched the Arrow EZ-IO Intraosseous Access Procedure Tray, enhancing its intraosseous vascular access portfolio. It includes all necessary components for intraosseous access, featuring the first FDA-cleared battery-powered driver that can be utilized in sterile environments. The tray is designed for quick and precise insertion, addressing the challenges clinicians face in obtaining vascular access during emergencies. However, risks associated with long-term use of catheters, such as infections and sepsis may pose challenges for market growth.
Rising Burden of Chronic Diseases to Increase the Market Size
The chronic disease burden is on a rise globally, owing to the increasing prevalence of chronic diseases, such as cancer, cardiovascular and urological disorders, and others, which necessitates frequent and long-term vascular access for treatments such as chemotherapy, dialysis, and medication administration, thereby driving the demand for various types of vascular access devices, including central venous catheters and peripheral IV catheters. Another factor contributing to the growing burden is the rising geriatric population, highly prone to catching such diseases. With the ongoing scenario, the future demand for vascular access devices is anticipated to increase further.
For instance, the National Institute of Health (NIH), anticipates that the number of adults 50 years and older suffer from at least one chronic disease, which will increase by 99.5% from 71.522 million in 2020 to 142.66 million in 2050. An estimated 48 million people, or 47% of all deaths globally, are expected to die from severe health-related suffering by 2060, an 87% increase from 26 million in 2016. It is anticipated that 83% of these deaths will occur in low and middle-income countries. As per World Health Organization (WHO) estimates, by 2050, there will be twice as many people 60 years or older on the planet with the population of 2.1 billion.
Design Improvements to Drive Market Demand
The established types of vascular access devices include central venous catheters (CVCs), arteriovenous fistulas (AVFs), and arteriovenous grafts (AVGs). Innovations in CVC tip and coating design have improved patency and blood flow rates. AVFs are preferred over CVCs as they are less prone to clotting and infection while providing reliable and adequate blood flow rates. With such design enhancements, the AVF creation devices have significant traction leading to market growth. Market players are taking chances to launch innovative products with enhanced designs. For instance, in September 2023, Laminate Medical Technologies announced that it received US-FDA clearance for its VasQ External Vascular Support device, designed to create AVFs for dialysis access. Notably, 80% of patients in trials using VasQ were able to remove central venous catheters within their first year of treatment, reducing the risk of infection compared to traditional AVFs. The VasQ device provides structural reinforcement to the vessels during AVF creation, promoting better arterial flow and functionality.
Drug Administration Application to Dominate Vascular Access Devices Market Share
The drug administration application of the vascular access devices market is anticipated to cover the highest market share. As these devices provide reliable, long-term access to the bloodstream, which is essential for patients needing frequent or prolonged intravenous therapies, such as chemotherapy or chronic disease management, reducing complications associated with traditional IV lines, such as infections and vein irritation, by minimizing the need for repeated needle sticks. A recent study published in the British Medical Journal in July 2024 examined the effectiveness of vascular access devices (VADs) in reducing infection rates among hospitalized patients. The study concluded that VADs along with specific safety measures reduce the chances of infection.
North America Dominates the Global Vascular Access Devices Market Share
North America is anticipated to hold major market share of the global vascular access devices market. North America's leadership in the demand for vascular access devices is attributed to its advanced healthcare infrastructure, rising prevalence of chronic diseases, technological innovations, supportive regulations, and demographic trends favoring increased healthcare needs. According to the United States Renal Data System 2023 Annual Data Report, published in April 2024, more than 85% of individuals who began hemodialysis used a catheter. Additionally, nearly three-quarters of the United States population started without permanent access, a significant increase from about 65% in 2018. This rise in number clearly shows an increasing consumption of such devices in North America causing it to hold the largest market share among other regions.
Future Market Scenario (2024 - 2031F)
The vascular access devices market has witnessed several remarkable futuristic advancements that are anticipated to shape the future of such devices. These advancements include wearable technology, remote monitoring of atrioventricular flow, use of biocompatible materials for product design, 3D printing technology, image-guided vascular access devices, and others. The USFDA approval of WavelinQ and Ellipsys, two vascular access devices that facilitate the creation of arteriovenous fistulas (AVFs) using minimally invasive techniques has paved a new path for more products in line with endovascular fistula creation. The of the most revolutionary advancement is the image-guided vascular access system, Ultreon 1.0 launched by Abbott in October 2023. This platform uses near-infrared light to provide high-definition, precise imaging from within the blood vessels, allowing the healthcare professional precise access to blood vessels even in the most complex anatomies.
Key Players Landscape and Outlook
The market witnessed some substantial market deals such as acquisitions, regulatory approvals, and product launches to expand the share of key players in the global vascular access devices market. In June 2023, Merit Medical announced two strategic acquisitions totaling USD 132.5 million to enhance its dialysis catheter portfolio. Merit Medical is acquiring dialysis catheters and a sealant system from AngioDynamics for USD 100 million, which complements its biopsy devices by preventing pneumothorax during lung biopsies. Additionally, Merit is purchasing the Surfacer catheter system from Bluegrass Vascular Technologies for USD 32.5 million, which facilitates central venous access.
In November 2023, BD launched the SiteRite 9 Ultrasound System, which is an advanced vascular access ultrasound designed to enhance clinician efficiency in placing peripherally inserted central catheters (PICCs), central venous catheters, and IV lines. SiteRite 9 aims to increase first-attempt insertion success and reduce unnecessary needlesticks, supporting BD's vision of a One-Stick Hospital Stay. The system received 510(k) Clearances in September 2023 and is available in the United States
market.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.